| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/02/2012 | US20120029060 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 02/02/2012 | US20120029059 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 02/02/2012 | US20120029058 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 02/02/2012 | US20120029057 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 02/02/2012 | US20120029029 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators |
| 02/02/2012 | US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors |
| 02/02/2012 | US20120028930 Flupirtine salts and polymorphs |
| 02/02/2012 | US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 02/02/2012 | US20120027693 Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise |
| 02/02/2012 | US20120027680 Oxime conjugates and methods for their formation and use |
| 02/01/2012 | EP2412714A1 Method for the industrial purification of biologically active phycotoxins |
| 02/01/2012 | EP2412705A1 Novel therapeutic agent for cognitive impairment |
| 02/01/2012 | EP1663262B1 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 02/01/2012 | EP1286989B1 Prodrug of an ICE inhibitor |
| 02/01/2012 | CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102335326A Chinese medicinal composition for invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain |
| 02/01/2012 | CN102335135A Functionalized nanoparticle, method for preparing the same and application thereof |
| 01/31/2012 | US8106218 Pharmaceutical compounds |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
| 01/26/2012 | WO2012012300A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | WO2012011673A2 Pharmaceutical composition including hesperetin as an active ingredient for promoting muscle cell differentiation or renewal |
| 01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | WO2012011572A1 Therapeutic agent for diastolic heart failure |
| 01/26/2012 | WO2012011548A1 Nitrogen-containing heterocyclic derivative |
| 01/26/2012 | WO2011150457A3 Haematopoietic-prostaglandin d2 synthase inhibitors |
| 01/26/2012 | US20120023600 Compositions and methods of use for antibodies of dickkopf-1 |
| 01/26/2012 | US20120022145 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 01/26/2012 | US20120022144 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof |
| 01/26/2012 | US20120022134 METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA |
| 01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | US20120021986 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 01/26/2012 | US20120021077 Synergistic herbal composition for treatment of rheumatic and musculo-skeletal disorders (rmsds) |
| 01/26/2012 | US20120021011 Anti-inflammatory pharmaceutical composition comprising extracts from broussonetia papyrifera and lonicera japonica |
| 01/26/2012 | US20120020958 Fibcd1 for the prevention and treatment of diseases |
| 01/26/2012 | US20120020956 Activation of sodium potassium atpase |
| 01/26/2012 | US20120020947 Compositions and methods for increasing lean muscle mass after exercise |
| 01/26/2012 | US20120020945 Food Supplement and Method for Enhancing Athletic Performance |
| 01/26/2012 | US20120020936 Treatment of neurodegenerative disease using placental stem cells |
| 01/26/2012 | US20120020911 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 01/26/2012 | CA2806258A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | CA2805765A1 Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
| 01/25/2012 | EP2408469A1 Use of decorin for increasing muscle mass |
| 01/25/2012 | EP2408466A2 Agents and methods for tissue repair and regeneration |
| 01/25/2012 | EP1351707B9 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 01/25/2012 | CN102327602A Pharmaceutical composition comprising botulinum, a non ionicsurfactant, sodium chloride and sucrose |
| 01/25/2012 | CN102327492A Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury |
| 01/25/2012 | CN102327440A Chinese herbal medicine for treating deep multiple abscess |
| 01/25/2012 | CN102327418A Chinese medicinal herb for treating lumbar muscle degeneration |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101573 α-conotoxin MII analogs |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2383174C Method of treating cardio pulmonary diseases with no group compounds |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/22/2012 | CA2746922A1 Compositions and methods for increasing lean muscle mass after exercise |
| 01/19/2012 | WO2012009474A1 Method and formulations for treating sialic acid deficiencies |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008457A1 Composition for external application |
| 01/19/2012 | WO2012007688A1 Monoclonal antibodies to tetanus toxin |
| 01/19/2012 | WO2012006864A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 01/19/2012 | US20120016020 Solid dispersion of alpha-ketoamide derivatives |
| 01/19/2012 | US20120015992 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015895 Use Of RR/SR-Ractopamine |
| 01/19/2012 | CA2805222A1 Method and formulations for treating sialic acid deficiencies |
| 01/18/2012 | EP2407486A1 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP1430114B1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 01/18/2012 | CN102325793A Myostatin binding proteins |
| 01/18/2012 | CN102325768A Compounds and methods for the treatment of pain and other diseases |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319215A Vecuronium bromide liposome injection |
| 01/18/2012 | CN101810644B Production method of ant essential oil and ant oil soft capsule |
| 01/17/2012 | CA2602290C Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/12/2012 | WO2012005582A1 Nutritional composition for the stimulation of muscle protein synthesis |
| 01/12/2012 | WO2012005568A1 Nutritional composition for the stimulation of muscle protein synthesis |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012004966A1 Therapeutic agent for fibromyalgia containing etanercept |
| 01/12/2012 | WO2012004291A1 Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients. |
| 01/12/2012 | US20120010291 CREATINE Beta-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
| 01/12/2012 | US20120010287 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| 01/12/2012 | US20120010176 Utrophin promoter activity upregulation for the treatment of muscular dystrophy |
| 01/12/2012 | US20120009288 Use of acacia extracts and their compounds on inhibition of xanthine oxidase |
| 01/12/2012 | US20120009268 Modified Virus Vectors and Methods of Making and Using the Same |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | CA2802216A1 Tetrahydrocarboline derivative |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102311407A Preparation method for S(+) toloperisone and pharmaceutical use thereof |
| 01/11/2012 | CN102309693A Preparation method of total flavones of bitter bamboo leaves |
| 01/11/2012 | CN102309613A Traditional Chinese medicine (TCM) prescription for treating lumbar muscle strain |
| 01/11/2012 | CN102309576A Preparation method of uncaria total alkaloids |
| 01/11/2012 | CN102309475A Levocarnitine for injection and preparation method thereof |